News

Intent that RoslinCT is to perform technology transfer and commercial manufacture of Omisirge® at RoslinCT’s cell therapy manufacturing facility in Hopkinton, MA.

• Omisirge®is a commercialized mismatched unrelated cell therapy derived from the youngest donor source and banked for ease of infusion for patients with hematological malignancies.

The 2025 Life Sciences Outlook highlights the industry's promising growth, driven by digital advancements, increased investor confidence, and innovative product development.

Universities are well aware of the strategic importance of commercialising innovation and a recent report shows that four UK universities are in the top ten in Europe for numbers of startups based on university patent applications¹.

This article is part 1 of a series of 5 articles relating to Patent Box.

Praetura Ventures is relaunching its PraeSeed program, offering up to £200k in investment and expert support to pre-seed North West startups through the Northern Powerhouse Investment Fund II.

The 2024 Bionow Awards dinner marked an exceptional evening of recognition and celebration, as 342 distinguished guests gathered at the Concorde Conference Centre on 6th March to honour those who have demonstrated outstanding ingenuity and dedication.

The Haverhill contamination control specialists will be appearing at two Space exhibitions in consecutive weeks as trade show season ramps up

Struggling to Hire? Unlock Top Talent Faster with This BIONOW Exclusive

Finding and retaining the right talent is tough, especially in the competitive life sciences sector. As a BIONOW member, you now have exclusive access to Omni’s expert hiring solutions, designed to help businesses find, attract, and retain top leaders and specialists faster and smarter. Whether you're scaling up, strengthening leadership, or refining your hiring strategy, our team—including former AstraZeneca and industry experts—delivers the results you need.

ITS is delighted to announce the appointment of Gareth Davies as Non-Executive Director.

The University of Liverpool’s spin-out company, Galytx, has signed an exclusive licensing agreement with dermatology biotech company Quodria Ltd. Together, they will develop a first-in-class treatment for Atopic Dermatitis (AD), a form of eczema.

The University of Manchester is a global leader in life sciences with cutting-edge research, advanced technology, and world-class facilities. Key areas include genomics, neuroscience, cancer, immunology, and digital health.

By embracing these strategies, the life sciences industry can navigate the dynamic landscape and achieve sustainable growth.

Key takeaways and how Morula Health is making a difference

Bruntwood SciTech - Biology Lecture Series - NAMs: a future vision

Terumo Aortic, a global medical device company, dedicated to developing solutions for aortic and peripheral vascular disease is investing in a new ‘Final Pack’ facility for its impressive Glasgow facility. The Renfrewshire-based site is responsible for the manufacture of vascular products that are used worldwide by surgeons and interventional radiologists to treat patients with aortic disease.

ApconiX is delighted to welcome Jessica Ferguson as an associate scientist in the Safety Science group.

Suffolk contamination control specialists have fleshed out some critical early stages advice for clients looking to start a new cleanroom build

12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.

At one of Insider’s latest roundtables, sponsored by the University of Manchester Innovation Factory, investment professionals, property experts, and spin-out CEOs discussed what’s working, what’s missing, and what makes Manchester’s innovation economy unique.

ADCs represent an attractive investment proposition, but the value proposition needs to be clearly communicated argues Nick Massouh, Biotechnology Sector Lead at Tarleton.

In a fascinating discussion, Gabriella Elia and Chris Hulme explore the communication challenges of AMR with Professor Janet Hemingway, founder of iiCON; Dr Neil Murray, CEO of Renewvax and Ava Knowles, student at Liverpool’s Life Science UTC.

Applications are now open for the NE Talent Bridge Internship Programme. Funded by Santander Universities, this scheme provides funding to businesses to support the salary of a Durham University intern over the summer period. This initiative offers businesses access to highly skilled students and graduates while helping to develop future talent.

Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that extends the shelf life of fresh whole blood for up to three days at refrigerated temperatures (2-8°C) - without cryopreservation or chemical fixation.

Lant Medical is pioneering a breakthrough solution: a non-antibiotic treatment designed to eradicate H. Pylori safely and effectively. This new investment will facilitate the necessary clinical trials to validate the treatments efficacy.

At the end of last year, in Manchester, Mills & Reeve hosted a roundtable focused on investment, and how the city and the wider North West is championing women’s health businesses through funding, partnerships and support.

Northern Hospitality: How to collaborate with NHS Trusts for Trials, Evaluations and Procurement. 

A ducted plenum is a crucial component in cleanroom design, ensuring controlled airflow, contamination prevention and compliance with strict industry regulations. While it offers many benefits, it also presents certain challenges that must be carefully considered.

At a recent event, Aon’s Suzanne Courtney, Human Capital Industry Leader, Life Sciences, EMEA, together with Matt Robinson, Life Science Industry Leader and Keaton Hoffman, Partner, Life Sciences, EMEA, discussed the impact of the EU’s upcoming Pay Transparency Directive and the lessons we can learn from it.

A new online course on Troubleshooting in Liquid Chromatography is now open for registration, offering participants the opportunity to enhance their skills and knowledge in this essential area of laboratory practice. The course is completely free and designed to provide systematic and comprehensive training over seven weeks.

ApconiX is delighted to welcome Josh Wright who joins for a year’s placement having just completed his second year of a bachelor’s degree in business and economics. Josh becomes part of the marketing and business development team and will be working with Dr Cynara Livera, Head of Marketing and Dr Laurence Bishop, Head of Business Development and Deputy Director.